Chugai Pharmaceutical Co. fell 7.3%, the largest intraday decline since August 2025, after the company said it had ended the ...

The blockbuster weight loss drug sold as Ozempic and Wegovy will soon go generic in countries that are home to 40% of the ...

One of these assets is catalyst-driven; the other isn't.

Structure Therapeutics advances oral therapies for diabetes, obesity, and pulmonary disease through its clinical-stage drug pipeline.

Letters: GLP-1 medicines work best alongside lifestyle adjustments, writes Dr Sam Robson. Plus letters from Anne Williams, Siân Williams, and a reader who has had success with Mounjaro ...

Wall Street and healthcare stocks sank as Eli Lilly was downgraded, Novo’s Wegovy HD won FDA approval, and drug supply risks rose.

GLP-1 medications like semaglutide (Ozempic) may offer unexpected mental health benefits alongside weight loss. A large study found major drops in depression, anxiety, and psychiatric-related hospital ...

The global weight-loss treatment market has not had it so good in ages. From a ‘class’ drug priced at a prohibitive ₹10,000 a month and above, the jab’s cost dr ...

An all-of-the-above strategy is needed to head off Australia's worsening obesity problem, bipartisan research finds.

Eli Lilly and Company (NYSE:LLY) is one of the best forever stocks to buy now. On March 16, Eli Lilly and Company (NYSE:LLY) ...

It’s frustrating to watch, given my field of study.

Researchers at the University of Colorado Boulder have identified a molecule in Burmese python blood that suppresses appetite ...